07:00 , Aug 16, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Endocrine/metabolic disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Diabetes BR serine/threonine kinase 2 (BRSK2) Human tissue and mouse studies suggest antagonizing BRSK2 could help treat type 2 diabetes. In human and mouse...